Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis

FASEB Journal

Volumn 24, Issue 12, 2010, Pages 4835-4843

  Patel, Hetal B ^a   Bombardieri, Michele ^a   Sampaio, André L F ^a   D'Acquisto, Fulvio ^a   Gray, Mohini ^b   Grieco, Paolo ^c   Getting, Stephen J ^d   Pitzalis, Costantino ^a   Perretti, Mauro ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF WESTMINSTER   (United Kingdom)

Author keywords

Bone erosion; Cytokines; G protein coupled receptor; Melanocortins; Osteoclasts

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BONE EROSION; BONE MARROW CELL; CELL STRUCTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERUM; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CELL DIFFERENTIATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; INTERLEUKIN-1BETA; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOCLASTS; OSTEOGENESIS; POLYMERASE CHAIN REACTION; RECEPTOR, MELANOCORTIN, TYPE 3;

MUS;

EID: 78649749715     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-167759     Document Type: Article

References (47)

1. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852
2. Gonzalez-Rey, E., Chorny, A., and Delgado, M. (2007) Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 7, 52-63
3. Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A., Perretti, M., Rossi, A. G., and Wallace, J. L. (2007) Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332
4. Serhan, C. N., and Savill, J. (2005) Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191-1197
5. Gilroy, D. W., Lawrence, T., Perretti, M., and Rossi, A. G. (2004) Inflammatory resolution: new opportunities for drug discovery. Nat. Rev. Drug. Discov. 3, 401-416
6. Catania, A., Gatti, S., Colombo, G., and Lipton, J. M. (2004) Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 56, 1-29
7. Gutman, A. B., and Yu, T. F. (1950) Effects of adrenocorticotropic hormone (ACTH) in gout. Am. J. Med. 9, 24-30
8. Hench, P. S., Kendall, E. C., Slocumb, C. H., and Polley, H. E. (1949) The effect of the adrenal cortex (17-hydroxy-11-dehydrocortisone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc. Staff Meet. Mayo Clin. 24, 181-197
9. Ritter, J., Kerr, L. D., Valeriano-Marcet, J., and Spiera, H. (1994) ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems. J. Rheumathol. 21, 696-699
10. Artuc, M., Bohm, M., Grutzkau, A., Smorodchenko, A., Zuberbier, T., Luger, T., and Henz, B. M. (2006) Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH. J. Invest. Dermatol. 126, 1976-1981
11. Brzoska, T., Luger, T. A., Maaser, C., Abels, C., and Bohm, M. (2008) Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, anti-inflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr. Rev. 29, 581-602
12. Ceriani, G., Diaz, J., Murphree, S., Catania, A., and Lipton, J. M. (1994) The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. Neuroimmunomodulation 1, 28-32
13. Gantz, I., and Fong, T. M. (2003) The melanocortin system. Am. J. Physiol. Endocrinol. Metab. 284, E468-E474
14. Alexander, S. P. H., Mathie, A., and Peters, J. A. (2009) Guide to receptors and channels, 4th edition. Br. J. Pharmacol. 158(Suppl. 1), S1-S253
15. Getting, S. J. (2006) Targeting melanocortin receptors as potential novel therapeutics. Pharmacol. Ther. 111, 1-15
16. Leoni, G., Patel, H. B., Sampaio, A. L., Gavins, F. N., Murray, J. F., Grieco, P., Getting, S. J., and Perretti, M. (2008) Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion. FASEB J. 22, 4228-4238
17. Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X. M., Yu, H., Rosenblum, C. I., Vongs, A., Feng, Y., Cao, L., Metzger, J. M., Strack, A. M., Camacho, R. E., Mellin, T. N., Nunes, C. N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D. E., Chen, H. Y., and Van der Ploeg, L. H. (2000) Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102
18. Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., and Brenner, M. B. (2002) Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689-1692
19. Matsumoto, I., Maccioni, M., Lee, D. M., Maurice, M., Simmons, B., Brenner, M., Mathis, D., and Benoist, C. (2002) How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat. Immunol. 3, 360-365
20. Ji, H., Ohmura, K., Mahmood, U., Lee, D. M., Hofhuis, F. M., Boackle, S. A., Takahashi, K., Holers, V. M., Walport, M., Gerard, C., Ezekowitz, A., Carroll, M. C., Brenner, M., Weissleder, R., Verbeek, J. S., Duchatelle, V., Degott, C., Benoist, C., and Mathis, D. (2002) Arthritis critically dependent on innate immune system players. Immunity 16, 157-168
21. Kronke, G., Katzenbeisser, J., Uderhardt, S., Zaiss, M. M., Scholtysek, C., Schabbauer, G., Zarbock, A., Koenders, M. I., Axmann, R., Zwerina, J., Baenckler, H. W., van den Berg, W., Voll, R. E., Kuhn, H., Joosten, L. A., and Schett, G. (2009) 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J. Immunol. 183, 3383-3389
22. Grieco, P., Balse, P. M., Weinberg, D., MacNeil, T., and Hruby, V. J. (2000) D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity. J. Med. Chem. 43, 4998-5002
23. Kouskoff, V., Korganow, A. S., Duchatelle, V., Degott, C., Benoist, C., and Mathis, D. (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87, 811-822
24. Takeshita, S., Kaji, K., and Kudo, A. (2000) Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15, 1477-1488
25. Huggins, A., Paschalidis, N., Flower, R. J., Perretti, M., and D'Acquisto, F. (2009) Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation. FASEB J. 23, 985-996
26. Mack, M., Cihak, J., Simonis, C., Luckow, B., Proudfoot, A. E., Plachy, J., Bruhl, H., Frink, M., Anders, H. J., Vielhauer, V., Pfirstinger, J., Stangassinger, M., and Schlondorff, D. (2001) Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J. Immunol. 166, 4697-4704
27. Zhou, H. F., Chan, H. W., Wickline, S. A., Lanza, G. M., and Pham, C. T. (2009) AlphaV beta3-targeted nanotherapy suppresses inflammatory arthritis in mice. FASEB J. 23, 2978-2985
28. Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., Khoo, W., Wakeham, A., Dunstan, C. R., Lacey, D. L., Mak, T. W., Boyle, W. J., and Penninger, J. M. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315-323
29. Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., DeRose, M., Elliott, R., Colombero, A., Tan, H. L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T. M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., and Boyle, W. J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319
30. Lacey, D. L., Timms, E., Tan, H. L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., Hsu, H., Sullivan, J., Hawkins, N., Davy, E., Capparelli, C., Eli, A., Qian, Y. X., Kaufman, S., Sarosi, I., Shalhoub, V., Senaldi, G., Guo, J., Delaney, J., and Boyle, W. J. (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93, 165-176
31. Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337-342
32. Binder, N. B., Niederreiter, B., Hoffmann, O., Stange, R., Pap, T., Stulnig, T. M., Mack, M., Erben, R. G., Smolen, J. S., and Redlich, K. (2009) Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat. Med. 15, 417-424
33. Schaller, M., Burton, D. R., and Ditzel, H. J. (2001) Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat. Immunol. 2, 746-753
34. Ji, H., Pettit, A., Ohmura, K., Ortiz-Lopez, A., Duchatelle, V., Degott, C., Gravallese, E., Mathis, D., and Benoist, C. (2002) Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 196, 77-85
35. Nigrovic, P. A., Binstadt, B. A., Monach, P. A., Johnsen, A., Gurish, M., Iwakura, Y., Benoist, C., Mathis, D., and Lee, D. M. (2007) Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1. Proc. Natl. Acad. Sci. U. S. A. 104, 2325-2330
36. Dufton, N., Hannon, R., Brancaleone, V., Dalli, J., Patel, H. B., Gray, M., D'Acquisto, F., Buckingham, J. C., Perretti, M., and Flower, R. J. (2010) The anti-inflammatory role of the murine formyl peptide receptor Fpr2: ligand-specific effects on leukocyte responses and experimental inflammation J. Immunol. 184, 2611-2619
37. Solomon, S., Rajasekaran, N., Jeisy-Walder, E., Snapper, S. B., and Illges, H. (2005) A crucial role for macrophages in the pathology of K/B x N serum-induced arthritis. Eur. J. Immunol. 35, 3064-3073
38. Getting, S. J., Lam, C. W., Chen, A. S., Grieco, P., and Perretti, M. (2006) Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 20, 2234-2241
39. Adachi, S., Nakano, T., Vliagoftis, H., and Metcalfe, D. D. (1999) Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone. J. Immunol. 163, 3363-3368
40. Getting, S. J., Allcock, G. H., Flower, R., and Perretti, M. (2001) Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol. 69, 98-104
41. Star, R. A., Rajora, N., Huang, J., Stock, R. C., Catania, A., and Lipton, J. M. (1995) Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. U. S. A. 92, 8016-8020
42. Lipton, J. M., and Catania, A. (1997) Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today 18, 140-145
43. Ruschpler, P., Lorenz, P., Eichler, W., Koczan, D., Hanel, C., Scholz, R., Melzer, C., Thiesen, H. J., and Stiehl, P. (2003) High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res. Ther. 5, R241-R252
44. Zhong, Q., Sridhar, S., Ruan, L., Ding, K. H., Xie, D., Insogna, K., Kang, B., Xu, J., Bollag, R. J., and Isales, C. M. (2005) Multiple melanocortin receptors are expressed in bone cells. Bone 36, 820-831
45. Tolar, J., Tope, W. D., and Neglia, J. P. (2004) Leukotriene-receptor inhibition for the treatment of systemic mastocytosis. N. Engl. J. Med. 350, 735-736
46. Grassel, S., Opolka, A., Anders, S., Straub, R. H., Grifka, J., Luger, T. A., and Bohm, M. (2009) The melanocortin system in articular chondrocytes: melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of alphamelanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components. Arthritis Rheum. 60, 3017-3027
47. Schlesinger, N. (2008) Overview of the management of acute gout and the role of adrenocorticotropic hormone. Drugs 68, 407-415